1. Inici
  2. Publicacions
  3. Dietary practices in isovaleric acidemia: A European survey.

Dietary practices in isovaleric acidemia: A European survey.

Data de publicació:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Pinto, A
  • Daly, A
  • Evans, S
  • Almeida, MF
  • Assoun, M
  • Belanger-Quintana, A
  • Bernabei, S
  • Bollhalder, S
  • Cassiman, D
  • Champion, H
  • Chan, H
  • de Boer, F
  • de Laet, C
  • de Meyer, A
  • Desloovere, A
  • Dianin, A
  • Dixon, M
  • Dokoupil, K
  • Dubois, S
  • Eyskens, F
  • Faria, A
  • Fasan, I
  • Favre, E
  • Feillet, F
  • Fekete, A
  • Gallo, G
  • Gingell, C
  • Gribben, J
  • Kaalund-Hansen, K
  • Horst, N
  • Jankowski, C
  • Janssen-Regelink, R
  • Jones, I
  • Jouault, C
  • Kahrs, GE
  • Kok, IL
  • Kowalik, A
  • Laguerre, C
  • Le Verge, S
  • Lilje, R
  • Maddalon, C
  • Mayr, D
  • Meyer, U
  • Micciche, A
  • Robert, M
  • Rocha, JC
  • Rogozinski, H
  • Rohde, C
  • Ross, K
  • Saruggia, I
  • Schlune, A
  • Singleton, K
  • Sjoqvist, E
  • Stolen, LH
  • Terry, A
  • Timmer, C
  • Tomlinson, L
  • Tooke, A
  • Vande Kerckhove, K
  • van Dam, E
  • van den Hurk, T
  • van der Ploeg, L
  • van Driessche, M
  • van Rijn, M
  • van Teeffelen-Heithoff, A
  • van Wegberg, A
  • Vasconcelos, C
  • Vestergaard, H
  • Webster, D
  • White, FJ
  • White, L
  • Zweers, H
  • MacDonald, A

Grups d'Investigació

Abstract

BACKGROUND: In Europe, dietary management of isovaleric acidemia (IVA) may vary widely. There is limited collective information about dietetic management. AIM: To describe European practice regarding the dietary management of IVA, prior to the availability of the E-IMD IVA guidelines (E-IMD 2014). METHODS: A cross-sectional questionnaire was sent to all European dietitians who were either members of the Society for the Study of Inborn Errors of Metabolism Dietitians Group (SSIEM-DG) or whom had responded to previous questionnaires on dietetic practice (n = 53). The questionnaire comprised 27 questions about the dietary management of IVA. RESULTS: Information on 140 patients with IVA from 39 centres was reported. 133 patients (38 centres) were given a protein restricted diet. Leucine-free amino acid supplements (LFAA) were routinely used to supplement protein intake in 58% of centres. The median total protein intake prescribed achieved the WHO/FAO/UNU [2007] safe levels of protein intake in all age groups. Centres that prescribed LFAA had lower natural protein intakes in most age groups except 1 to 10 y. In contrast, when centres were not using LFAA, the median natural protein intake met WHO/FAO/UNU [2007] safe levels of protein intake in all age groups. Enteral tube feeding was rarely prescribed. CONCLUSIONS: This survey demonstrates wide differences in dietary practice in the management of IVA across European centres. It provides unique dietary data collectively representing European practices in IVA which can be used as a foundation to compare dietary management changes as a consequence of the first E-IMD IVA guidelines availability.

Dades de la publicació

ISSN/ISSNe:
2214-4269, 2214-4269

Molecular Genetics And Metabolism Reports  ELSEVIER SCIENCE BV

Tipus:
Article
Pàgines:
16-22
PubMed:
28275552
Factor d'Impacte:
0,523 SCImago ℠
Quartil:
Q3 SCImago ℠

Cites Rebudes en Web of Science: 14

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Keywords

  • Isovaleric acidemia; Leucine; Leucine free l-amino acids; Natural protein; Protein restricted diet

Projectes associats

ESTUDIO POSTAUTORIZACIÓN DE SEGURIDAD (EPAS) NO INTERVENCIONAL PARA EVALUAR LA SEGURIDAD A LARGO PLAZO DEL TRATAMIENTO CON ORFADIN EN LA TIROSINEMIA HEREDITARIA TIPO 1 (TH-1) EN LA PRÁCTICA CLÍNICA ESTÁNDAR.

Investigador Principal: ISIDRO VITORIA MIÑANA

SWE-NIT-2013-01 . 2014

ESTUDIO OBSERVACIONAL, AMBISPECTIVO DE HISTORIA NATURAL EN PACIENTES CON MUCOPOLISACARIDOSIS TIPO IIIA (MPS IIIA) O SÍNDROME DE SANFILIPPO TIPO A.

Investigador Principal: ISIDRO VITORIA MIÑANA

EST-SFA-2013-01 . 2014

OPTIMIZACIÓN DE LAS TERAPIAS DE SUSTITUCIÓN ENZIMÁTICA EN PACIENTES CON ENFERMEDADES DE DEPÓSITO LISOSOMAL.

Investigador Principal: JOSÉ LUIS POVEDA ANDRÉS

JLP-ELO-2017-01

ESTUDIO DE RESULTADOS DE HUNTER: REGISTRO OBSERVACIONAL, INTERNACIONAL Y MULTICÉNTRICO A LARGO PLAZO DE PACIENTES CON SÍNDROME DE HUNTER (MUCOPOLISACARIDOSIS DE TIPO II, MPS II).

Investigador Principal: ISIDRO VITORIA MIÑANA

SHI-IDU-2011-01 . 2014

PROTOCOLO DEL REGISTRO DE LA ENFERMEDAD DE GAUCHER.

Investigador Principal: ISIDRO VITORIA MIÑANA

GEN-GAU-2013-01 . 2018

PROTOCOLO DE VIGILANCIA DEL E-HOD/CYSTADANE.

Investigador Principal: JAIME DALMAU SERRA

ORP-CYS-2014-01

MONITORIZACIÓN E INDIVIDUALIZACIÓN POSOLÓGICA DE GLUCOCEREBROSIDASA EN PACIENTES GAUCHER TIPO I.

Investigador Principal: ISIDRO VITORIA MIÑANA

FIS-IMI-2012-01

Compartir la publicació